Solutions

Driving Innovation in Accessing Point-of-Care Testing Diagnostic Data

Workflow Services has partnered with the FDA in its Diagnostic Data Program to collect and provide vital POCT data in pharmacy settings. 

Data Collection and Transmission Accelerating Pharmacy Care Delivery

The demand for clinical services, including point-of-care testing (POCT) services, in pharmacy settings has significantly increased in recent years. Every indication points to this trend continuing, which means removing barriers to pharmacy service delivery is crucial.

The FDA responded to this need with the creation of their Diagnostic Data Program. Their aim is to address and eliminate key barriers to capture the full potential of diagnostic data.

Workflow Services will provide the FDA with diagnostic testing data from pharmacy settings. Our goal is to increase accessibility and implementation of POCT and low-acuity healthcare services to meet the increasing demand. Access to this data will also provide actionable information related to viruses’ location and spread, empowering early intervention to minimize transmission and suppress outbreaks.

We are proud to partner with the FDA and look forward to working together to drive further innovation and usher in new technological ways of accessing point-of-care tests and using diagnostic data for years to come.

Discover how the Diagnostic Data Program
supports partners to increase POCT accessibility

The Workflow Services Solution

  • 1 - Connect with Patients

    Patients discover services you deliver with pre-registration and walk-ins supported.

  • 2 - Deliver Medical Services

    Efficient and accurate digital protocols simplify care delivery and support pharmacy staff.

  • 3 - Streamline Payment and Reimbursement

    Medical claims management with workflows designed to support accurate claims and accelerated reimbursement.

Why the FDA Selected Workflow Services for Its Groundbreaking Diagnostic Data Program

Want to Provide Healthcare Services but Don’t Know Where to Start?

In our new whitepaper, Nancy Gagliano, MD, MBA, details state-by-state point-of-care legislation and the scope of practice and capabilities for pharmacists in each state. Dr. Gagliano outlines the growing demand for care access and how pharmacies can leverage their pharmacists to fill the gaps in healthcare.

What Our Clients are Saying